Influenza and pneumococcal vaccination in chronic obstructive pulmonary disease (COPD)

Rennard, 2002, Impact of COPD in North America and Europe in 2000: subjects’ perspective of Confronting COPD International Survey, Eur Respir J, 20, 799, 10.1183/09031936.02.03242002 Peña, 2000, Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC Multicentre Epidemiological Study, Chest, 118, 981, 10.1378/chest.118.4.981 2004, National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care, Thorax, 59, 1 Celli, 2004, Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper, Eur Respir J, 23, 932, 10.1183/09031936.04.00014304 Lopalco, 2007, Panel of international experts concludes on influenza and pneumococcal vaccination in Europe, Euro Surveill, 12 Smith, 2006, Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), Morb Mortal Wkly Rep, 55, 1 1997, Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 46, 1 Nichol, 1999, Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease, Ann Intern Med, 130, 397, 10.7326/0003-4819-130-5-199903020-00003 Wongsurakiat, 2004, Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study, Chest, 125, 2011, 10.1378/chest.125.6.2011 Poole, 2006, Influenza vaccine for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002733 Nichol, 1999, The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease, Arch Intern Med, 159, 2437, 10.1001/archinte.159.20.2437 Pebody, 2005, Pneumococcal vaccination policy in Europe, Euro Surveill, 10, 174, 10.2807/esm.10.09.00564-en Granger, 2006, Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001390 Vila-Corcoles, 2006, Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study, Clin Infect Dis, 43, 860, 10.1086/507340 Dominguez, 2005, Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case–control study, Clin Infect Dis, 40, 1250, 10.1086/429236 Jackson, 2003, Effectiveness of pneumococcal polysaccharide vaccine in older adults, N Engl J Med (Printed), 348, 1747, 10.1056/NEJMoa022678 LeBaron, 1997, Impact of measurement and feedback on vaccination coverage in public clinics, 1988–1994, JAMA, 277, 631, 10.1001/jama.1997.03540320033031 Kamal, 2003, Determinants of adult influenza and pneumonia immunization rates, J Am Pharm Assoc (Washington, DC), 43, 403, 10.1331/154434503321831120 Kroneman, 2003, Influenza vaccination in Europe: an inventory of strategies to reach target populations and optimise vaccination uptake, Euro Surveill, 8, 130, 10.2807/esm.08.06.00418-en Bovier, 2001, Importance of patients’ perceptions and general practitioners’ recommendations in understanding missed opportunities for immunisations in Swiss adults, Vaccine, 19, 4760, 10.1016/S0264-410X(01)00223-7 Jiménez-García, 2005, Influenza vaccination coverage and related factors among Spanish patients with chronic obstructive pulmonary disease, Vaccine, 23, 3679, 10.1016/j.vaccine.2005.02.007 Jimenez, 2003, Influenza coverages in Spain and vaccination-related factors in the subgroup aged 50–64 years, Vaccine, 21, 3550, 10.1016/S0264-410X(03)00425-0 CDC. 2006–2007 Influenza prevention and control recommendations. Influenza vaccination coverage levels. Available from: 〈http://www.cdc.gov/flu/professionals/vaccination/coveragelevels.htm〉. Mayo, 2007, Influenza vaccination among persons with chronic respiratory diseases: coverage, related factors and time-trend, 1993–2001, Public Health, 121, 113, 10.1016/j.puhe.2006.09.009 Vila, 2005, Cobertura y asociación con variables clínicas de la vacunación antineumocócica en la población mayor de 65 años de Tarragona-Valls, Rev Esp Salud Pública, 79, 645 Ariñez-Fernandez, 2006, Determinants of pneumococcal vaccination among patients with chronic obstructive pulmonary disease in Spain, Hum Vaccin, 2, 99, 10.4161/hv.2756 2006, Influenza and pneumococcalvaccination coverage among persons aged >65 Years—United States, 2004–2005, Morb Mortal Wkly Rep, 55, 1065 Jiménez-García, 2007, Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain, J Infect, 54, 65, 10.1016/j.jinf.2005.11.020 Ndiaye, 2005, Interventions to improve influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among high-risk adults: a systematic review, Am J Prev Med, 28, 248, 10.1016/j.amepre.2005.02.016 Willis, 2005, Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: a report on recommendations of the Task Force on Community Preventive Services, MMWR Recomm Rep, 54, 1